About Us

Home » About Us » Paul Tselentis

Paul Tselentis

A photograph of Paul Tselentis

Paul Tselentis

Paul is the Chief Executive Officer of 24Haymarket, an investment firm focussed on early-stage, high growth investment opportunities in the healthcare, supply chain and climate technology, cybersecurity and enterprise technology verticals. Paul manages 24Haymarket’s day-to-day operations while also sitting on a number of boards of 24Haymarket investee companies including healthcare investments in the therapeutic, diagnostic and cell and gene therapy verticals. 

Paul has over 20 years of investment experience. Previous to co-founding 24Haymarket, he was a private equity investment professional at The Carlyle Group and CCMP Capital and began his career in investment banking at Lehman Brothers in New York. He has a Bachelors Degree in Economics from Harvard University.

Azadyne is a pre-clinical stage company exploiting a novel drug target and pathway that provides a paradigm shift in the treatment of autoimmune diseases